Rodrigo Azevedo Loiola
Rodrigo Loiola finished his bachelor’s degree in Nursing at Universidade de São Paulo (Brazil, 2004). Afterward, he concluded his master degree in Pharmacology (Universidade de São Paulo, Brazil – 2007) and Ph.D. in Molecular Biology (Universidade Federal de São Paulo, Brazil – 2011). Since then, he was awarded two postdoctoral fellowships from the Brazilian government to carry on his studies on inflammation and vascular system. Firstly, he investigated the effects of pollutants exposure on the immune system and its relation with genesis and/or progression of type 2 diabetes mellitus (T2DM), under the supervision of Dr. Sandra Farsky (Universidade de São Paulo, Brazil). In parallel, he participated on projects evaluating the suitability of magnetic nanoparticles as contrast agents for magnetic resonance imaging, and the therapeutical effect of lipid nanocapsules on the treatment of glioblastoma (2012-2015). More recently, he was awarded a fellowship to investigate the effects of T2DM and Multiple Sclerosis on the blood-brain barrier at William Harvey Research Institute (London, UK), under the supervision of Dr. Egle Solito (2015-2017). In September 2018, he joined LBHE at Jean Perrin Faculty of Science (Université d’Artois, Lens, France), under the supervision of Dr. Fabien Gosselet. Under the project MAGBRIS, in the frame of the European Innovative Research & Technological Development Projects in Nanomedicine, he will explore the therapeutic properties of secretome-loaded magnetic nanocapsules on the treatment of stroke.